ELV-101

N/A

Report date: 2024/12/30 13:26:31

Base Information

Drug NameELV-101
Drug Alias NameELV-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Follistatin-related protein 3
TargetsFollistatin-related protein 3
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElevian Inc
China Registration ClassN/A

Develop Information

Active CompaniesElevian Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A